Current research has indicated that OMT can inhibit the proliferation of IH cells via suppressing hypoxia-inducible factor 1A (HIF-1A) signaling, as well as inducing programmed cell death, suggesting its potential protective effect against IH and offering a novel approach for IH treatment [10]. This evidence concerns the gene HIF1A and isolated hemihyperplasia.